Cara L McDermott1, Ruth A Engelberg1, James Sibley1,2, Mohamed L Sorror3,4, J Randall Curtis1. 1. Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Cambia Palliative Care Center of Excellence, University of Washington, Seattle, Washington, USA. 2. Department of Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, Washington, USA. 3. Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington, USA. 4. Clinical Research Division, Fred Hutch, Seattle, Washington, USA.
Abstract
Background: Multiple chronic conditions (MCCs) are associated with increased intensity of end-of-life (EOL) care, but their effect is not well explored in patients with cancer. Objective: We examined EOL health care intensity and advance care planning (ACP) documentation to better understand the association between MCCs and these outcomes. Design: Retrospective cohort study. Setting/Subjects: Patients aged 18+ years at UW Medicine who died during 2010-2017 with poor prognosis cancer, with or without chronic liver disease, chronic pulmonary disease, coronary artery disease, dementia, diabetes with end-stage organ damage, end-stage renal disease, heart failure, or peripheral vascular disease. Measurements: ACP documentation 30+ days before death, in-hospital death, and inpatient or intensive care unit (ICU) admission in the last 30 days. We performed logistic regression for outcomes. Results: Of 15,092 patients with cancer, 10,596 (70%) had 1+ MCCs (range 1-8). Patients with cancer and heart failure had highest odds of hospitalization (odds ratio [OR] 1.67, 95% confidence interval [CI] 1.46-1.91), ICU admission (OR 2.06, 95% CI 1.76-2.41), or in-hospital death (OR 1.62, 95% CI 1.43-1.84) versus patients with cancer and other conditions. Patients with ACP 30+ days before death had lower odds of in-hospital death (OR 0.65, 95% CI 0.60-0.71), hospitalization (OR 0.67, 95% CI 0.61-0.74), or ICU admission (OR 0.71, 95% CI 0.64-0.80). Conclusions: Patients with ACP 30+ days before death had lower odds of high-intensity EOL care. Further research needs to explore how to best use ACP to ensure patients receive care aligned with patient and family goals for care.
Background: Multiple chronic conditions (MCCs) are associated with increased intensity of end-of-life (EOL) care, but their effect is not well explored in patients with cancer. Objective: We examined EOL health care intensity and advance care planning (ACP) documentation to better understand the association between MCCs and these outcomes. Design: Retrospective cohort study. Setting/Subjects: Patients aged 18+ years at UW Medicine who died during 2010-2017 with poor prognosis cancer, with or without chronic liver disease, chronic pulmonary disease, coronary artery disease, dementia, diabetes with end-stage organ damage, end-stage renal disease, heart failure, or peripheral vascular disease. Measurements: ACP documentation 30+ days before death, in-hospital death, and inpatient or intensive care unit (ICU) admission in the last 30 days. We performed logistic regression for outcomes. Results: Of 15,092 patients with cancer, 10,596 (70%) had 1+ MCCs (range 1-8). Patients with cancer and heart failure had highest odds of hospitalization (odds ratio [OR] 1.67, 95% confidence interval [CI] 1.46-1.91), ICU admission (OR 2.06, 95% CI 1.76-2.41), or in-hospital death (OR 1.62, 95% CI 1.43-1.84) versus patients with cancer and other conditions. Patients with ACP 30+ days before death had lower odds of in-hospital death (OR 0.65, 95% CI 0.60-0.71), hospitalization (OR 0.67, 95% CI 0.61-0.74), or ICU admission (OR 0.71, 95% CI 0.64-0.80). Conclusions: Patients with ACP 30+ days before death had lower odds of high-intensity EOL care. Further research needs to explore how to best use ACP to ensure patients receive care aligned with patient and family goals for care.
Entities:
Keywords:
ICU admission; advance care planning; advance directives; cancer; end-of-life health care
Authors: Craig C Earle; Bridget A Neville; Mary Beth Landrum; Jeffrey M Souza; Jane C Weeks; Susan D Block; Eva Grunfeld; John Z Ayanian Journal: Int J Qual Health Care Date: 2005-06-28 Impact factor: 2.038
Authors: Peter May; Charles Normand; J Brian Cassel; Egidio Del Fabbro; Robert L Fine; Reagan Menz; Corey A Morrison; Joan D Penrod; Chessie Robinson; R Sean Morrison Journal: JAMA Intern Med Date: 2018-06-01 Impact factor: 21.873
Authors: Igor Akushevich; Julia Kravchenko; Svetlana Ukraintseva; Konstantin Arbeev; Anatoly I Yashin Journal: Age Ageing Date: 2013-03-12 Impact factor: 10.668
Authors: Mei-Chin Hsieh; Trevor Thompson; Xiao-Cheng Wu; Timothy Styles; Mary B O'Flarity; Cyllene R Morris; Vivien W Chen Journal: Cancer Med Date: 2016-01-15 Impact factor: 4.452
Authors: Cara L McDermott; Ruth A Engelberg; Nita Khandelwal; Jill M Steiner; Laura C Feemster; James Sibley; William B Lober; J Randall Curtis Journal: Am J Hosp Palliat Care Date: 2020-10-21 Impact factor: 2.500
Authors: Sarah S Nouri; Deborah E Barnes; Ying Shi; Aiesha M Volow; Nikita Shirsat; Anne L Kinderman; Heather A Harris; Rebecca L Sudore Journal: Cancer Date: 2021-06-02 Impact factor: 6.921